Enzyme vs Boundless — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Boundless trades at Rp781.98 (market cap Rp240,04M, Rp78,35M 24h volume). The key difference: Boundless is the larger of the two by market cap, and Enzyme's circulating supply is 3,3M MLN versus 307,6M ZKC for Boundless. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Boundless for 13 Days on average.
| MLN | ZKC | |
|---|---|---|
Market Cap | Rp134,13M | Rp240,04M |
Volume (24h) | Rp104,56M | Rp78,35M |
Circulating Supply | 3,3M MLN | 307,6M ZKC |
Typical Hold Time | 28 Days | 13 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Boundless (ZKC) trades at Rp785.53 with a market cap of Rp241.84 million, showing a bearish technical signal with moving averages indicating selling pressure while oscillators remain neutral. The token faces resistance at Rp837 and finds support at Rp769, with current price action constrained within this range. No recent protocol updates or significant ecosystem developments have been reported.
Overall outlook remains cautious due to bearish technical indicators and limited fundamental catalysts. Key opportunities include potential bounce from support levels, while major risks involve low market cap volatility and lack of recent development activity. Investors should monitor for any protocol updates or exchange listing developments.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Boundless is a universal protocol designed to empower every blockchain with the capabilities of zero-knowledge (ZK) technology. It allows independent prover nodes to generate ZK proofs for layer 1 blockchains, applications, rollups, and infrastructure across all chains. By offloading computation to the Boundless network and verifying proofs on-chain, Boundless offers a consistent layer for scalability and interoperability, all without requiring changes to existing networks.
Read more on ZKC →